Ciprofloxacin-induced anaphylactoid reaction.
Kothur
Kavitha
K
Department of Pediatrics, Pediatric Pulmonology Unit, Advanced Pediatric Center, Post-Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, 160012, India.
Singh
Meenu
M
Dayal
Devi
D
D000284:Administration, Oral; D000293:Adolescent; D000707:Anaphylaxis / Q000139:chemically induced* / Q000628:therapy; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000009:adverse effects*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D002939:Ciprofloxacin / Q000008:administration & dosage / Q000009:adverse effects*; D004155:Diphenhydramine / Q000627:therapeutic use; D004837:Epinephrine / Q000627:therapeutic use; D005260:Female; D005440:Fluid Therapy; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D013566:Sympathomimetics / Q000627:therapeutic use
D000890:Anti-Infective Agents; D000893:Anti-Inflammatory Agents; D006634:Histamine H1 Antagonists; D013566:Sympathomimetics; D002939:Ciprofloxacin; D004155:Diphenhydramine; D006854:Hydrocortisone; D004837:Epinephrine